Germ Cell Tumors

• CLINICAL_TRIALS trial_result · 2026-04-14
  Clinical Trial Update: Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis [Phase 2]

  Phase 2 trial evaluating dose intensification in patients with relapsed, refractory germ cell tumors.

• CLINICAL_TRIALS trial_result · 2025-07-03
  Clinical Trial Update: Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors [Phase 2]

  Phase 2 clinical trial update comparing TIP (paclitaxel, ifosfamide, and cisplatin) with BEP (bleomycin, etoposide, and cisplatin) for previ…

• CLINICAL_TRIALS trial_result · 2021-05-14
  Clinical Trial Update: Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors [Phase 2]

  Phase 2 trial update of pazopanib in advanced and cisplatin-resistant germ cell tumors has completed.

• CLINICAL_TRIALS trial_result · 2019-03-05
  Clinical Trial Update: Avelumab in Refractory Testicular Germ Cell Cancer. [Phase 2]

  Phase 2 clinical trial update of avelumab in refractory testicular germ cell cancer has completed.

• CLINICAL_TRIALS trial_result · 2016-05-25
  Clinical Trial Update: Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors [Phase 2]

  Phase 2 trial evaluating fosaprepitant plus a 5-HT3 receptor antagonist and dexamethasone for chemotherapy-induced nausea and vomiting in pa…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-04-06
  Clinical Trial Update: Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors [Phase 3]

  A Phase 3 trial assessed a three-drug antiemetic regimen (aprepitant plus a 5-HT3 antagonist and dexamethasone) in patients with germ cell t…

• CLINICAL_TRIALS trial_result · 2014-06-12
  Clinical Trial Update: Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors [Phase 2]

  A Phase 2 trial comparing conventional-dose chemotherapy with high-dose sequential chemotherapy for poor-prognosis germ cell tumors has comp…

• CLINICAL_TRIALS trial_result · 2011-02-25
  Clinical Trial Update: High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II [Phase 2]

  Phase 2 TAXIF II evaluated high-dose chemotherapy with autologous stem cell transplantation in patients with poor-prognosis germ-cell tumors…

• CLINICAL_TRIALS trial_result · 2008-04-10
  Clinical Trial Update: Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy [Phase 1, Phase 2]

  Phase 1/2 study evaluating recombinant human thrombopoietin as supportive care for children receiving ifosfamide, carboplatin, and etoposide…